Tag: neurostimulation

Nuvectra receives FDA head-only MR-conditional approval for Algovita

Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system. Scott...

Mainstay Medical announces headline results from ReActiv8-B clinical study

Mainstay Medical International, a medical device company focused on commercialising ReActiv8, an implantable restorative neurostimulation system designed to treat an underlying cause of disabling...

Mainstay Medical announces the completion of all implants in the ReActiv8-B...

Mainstay Medical International, a medical device company focused on bringing to market ReActiv8, an implantable neurostimulation system to treat chronic low back pain, announces...

Neurostimulation can be part of the solution to the opioid crisis

The president of the United States of America has recently declared the opioid crisis in that country a “public health emergency”. In light of...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...

Neurostimulation protocol reduces spasticity in spinal cord injury

Spasticity is a common disorder experienced by patients with spinal cord injuries (SCI). Previous studies have shown that excitatory repetitive transcranial magnetic stimulation (rTMS)...

Wireless stimulation may ease migraine pain as well as drugs

A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs....